Cognoa ASD Diagnosis Aid
Pediatric Autism Spectrum Disorder Diagnosis Aid. De Novo DEN200069, from Cognoa, Inc. (Palo Alto, CA). Product code QPF, class 2.
As of Nov 21, 2026, DEN200069 is an FDA De Novo held by Cognoa, Inc., granted on Jun 2, 2021 after 211 days, with no recalls tied to it in FDA's recall database.
- Review time: 211 days
- Recalls: 0
- Cited as a predicate by: 3 devices
The Cognoa ASD Diagnosis Aid is intended for use by healthcare providers as an aid in the diagnosis of Autism Spectrum Disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider.
- Design
- Prospective, double-blinded, single-arm clinical validation study vs. clinical reference standard
- Enrolled
- 711
- Where
- 14 sites, US
- Primary endpoint
- Composite PPV greater than 65% and NPV greater than 85% vs. clinical reference standard in overall population; proportion of patients with no result; safety: AEs/SAEs collected
- Result
- PPV 81% (70%, 89%), NPV 98% (91%, 100%); no result rate 68% (64%, 73%) of 425 analysis subjects; no adverse events reported
- NeuroraK260064 · Argus Cognitive, Inc. · Oct 2, 2026
- Canvas DxK243558 · Cognoa, Inc. · Apr 11, 2025
- EarliPoint SystemK213882 · Earlitec Diagnostics, Inc. · Jun 8, 2022
- NeuroraK260064 · Argus Cognitive, Inc. · Oct 2, 2026
- EarliPoint AssessmentK253442 · Earlitec Diagnostics · Mar 5, 2026
- Canvas DxK243558 · Cognoa, Inc. · Apr 11, 2025
- EarliPoint SystemK243891 · Earlitec Diagnostics · Mar 26, 2025
- EarliPointK230337 · Earlitec Diagnostics, Inc. · Jun 29, 2023
- EarliPoint SystemK213882 · Earlitec Diagnostics, Inc. · Jun 8, 2022
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Nov 3, 2020
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1491
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files